Two Sigma Investments
CPRX

Two Sigma Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Two Sigma Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-159,305
Closed -$3.17M – 3247
2024
Q3 		$3.17M Buy
+159,305
New +$2.95M 0.01% 1357
2023
Q3 		– Sell
-25,400
Closed -$341K – 2987
2023
Q2 		$341K Sell
25,400
-1,159,025
-98% -$16.7M ﹤0.01% 2479
2023
Q1 		$19.6M Sell
1,184,425
-740,665
-38% -$12.2M 0.06% 381
2022
Q4 		$35.8M Buy
1,925,090
+190,367
+11% +$2.93M 0.11% 221
2022
Q3 		$22.3M Buy
1,734,723
+1,271,398
+274% +$15.1M 0.08% 304
2022
Q2 		$3.25M Sell
463,325
-611,957
-57% -$4.49M 0.01% 949
2022
Q1 		$8.91M Buy
1,075,282
+314,203
+41% +$2.22M 0.03% 650
2021
Q4 		$5.15M Buy
761,079
+646,508
+564% +$4.25M 0.01% 1179
2021
Q3 		$607K Sell
114,571
-231,494
-67% -$1.27M ﹤0.01% 3068
2021
Q2 		$1.99M Sell
346,065
-235,188
-40% -$1.21M ﹤0.01% 1871
2021
Q1 		$2.68M Buy
581,253
+212,182
+57% +$843K 0.01% 1483
2020
Q4 		$1.23M Buy
+369,071
New +$1.24M ﹤0.01% 1837
2020
Q3 		– Sell
-426,197
Closed -$1.97M – 3161
2020
Q2 		$1.97M Buy
426,197
+413,126
+3,161% +$1.86M 0.01% 1109
2020
Q1 		$50K Sell
13,071
-699,686
-98% -$2.87M ﹤0.01% 2930
2019
Q4 		$2.67M Buy
+712,757
New +$3.33M 0.01% 1362
2019
Q1 		– Sell
-141,004
Closed -$271K – 3089
2018
Q4 		$271K Buy
+141,004
New +$404K ﹤0.01% 2521
2018
Q3 		– Sell
-21,673
Closed -$68K – 3238
2018
Q2 		$68K Buy
21,673
+2,970
+16% +$9.01K ﹤0.01% 3222
2018
Q1 		$45K Sell
18,703
-388,472
-95% -$1.29M ﹤0.01% 3068
2017
Q4 		$1.59M Buy
+407,175
New +$1.35M 0.01% 1636
2016
Q2 		– Sell
-61,434
Closed -$72K – 2941
2016
Q1 		$72K Buy
+61,434
New +$95.3K ﹤0.01% 2708

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Two Sigma Investments's CPRX Position: Q4 2024 in Review

Two Sigma Investments sold out of Catalyst Pharmaceutical (CPRX) in Q4 2024, closing a stake of 159,305 shares — an estimated $3.17M sold.

Two Sigma Investments first reported a position in CPRX in Q1 2016 and held it in 20 quarters. The position peaked at $35.8M in Q4 2022. 336 funds tracked by Wall St. Rank hold CPRX as of Q4 2024.

  • Two Sigma Investments reported no remaining Catalyst Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Investments sold 159,305 Catalyst Pharmaceutical shares in Q4 2024, an estimated $3.17M.
  • Two Sigma Investments first reported a position in Catalyst Pharmaceutical in Q1 2016 and held it in 20 quarters.
  • Two Sigma Investments's Catalyst Pharmaceutical position peaked at $35.8M in Q4 2022.
  • 336 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.